Cargando…

Early initiation of renal replacement therapy in critically ill patients: a meta-analysis of randomized clinical trials

BACKGROUND: Acute kidney injury (AKI) is strongly associated with high morbidity and mortality of critically ill patients. In the last years several different biological markers with higher sensitivity and specificity for the occurrence of renal impairment have been developed in order to promptly re...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasin, Laura, Boraso, Sabrina, Tiberio, Ivo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492439/
https://www.ncbi.nlm.nih.gov/pubmed/31039744
http://dx.doi.org/10.1186/s12871-019-0733-7
_version_ 1783415147010719744
author Pasin, Laura
Boraso, Sabrina
Tiberio, Ivo
author_facet Pasin, Laura
Boraso, Sabrina
Tiberio, Ivo
author_sort Pasin, Laura
collection PubMed
description BACKGROUND: Acute kidney injury (AKI) is strongly associated with high morbidity and mortality of critically ill patients. In the last years several different biological markers with higher sensitivity and specificity for the occurrence of renal impairment have been developed in order to promptly recognize and treat AKI. Nonetheless, their potential role in improving patients’ outcome remains unclear since the effectiveness of an “earlier” initiation of renal replacement therapy (RRT) is still debated. Since one large, high-quality randomized clinical trial has been recently pubblished, we decided to perform a meta-analysis of all the RCTs ever performed on “earlier” initiation of RRT versus standard RRT in critically ill patients with AKI to evaluate its effect on major outcomes. METHODS: Pertinent studies were independently searched in BioMedCentral, PubMed, Embase, and Cochrane Central Register of clinical trials. The following inclusion criteria were used: random allocation to treatment (“earlier” initiation of RRT versus later/standard initiation); critically ill patients. RESULTS: Ten trials randomizing 2214 patients, 1073 to earlier initiation of RRT and 1141 to later initiation were included. No difference in mortality (43.3% (465 of 1073) for those receiving early RRT and 40.8% (466 of 1141) for controls, p = 0.97) and survival without dependence on RRT (3.6% (34 of 931) for those receiving early RRT and 4.2% (40 of 939) for controls, p = 0.51) were observed in the overall population. On the contrary, early initiation of RRT was associated with a significant reduction in hospital length of stay. No differences in occurrence of adverse events were observed. CONCLUSIONS: Our study suggests that early initiation of RRT in critically ill patients with AKI does not provide a clinically relevant advantage when compared with standard/late initiation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12871-019-0733-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6492439
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64924392019-05-08 Early initiation of renal replacement therapy in critically ill patients: a meta-analysis of randomized clinical trials Pasin, Laura Boraso, Sabrina Tiberio, Ivo BMC Anesthesiol Research Article BACKGROUND: Acute kidney injury (AKI) is strongly associated with high morbidity and mortality of critically ill patients. In the last years several different biological markers with higher sensitivity and specificity for the occurrence of renal impairment have been developed in order to promptly recognize and treat AKI. Nonetheless, their potential role in improving patients’ outcome remains unclear since the effectiveness of an “earlier” initiation of renal replacement therapy (RRT) is still debated. Since one large, high-quality randomized clinical trial has been recently pubblished, we decided to perform a meta-analysis of all the RCTs ever performed on “earlier” initiation of RRT versus standard RRT in critically ill patients with AKI to evaluate its effect on major outcomes. METHODS: Pertinent studies were independently searched in BioMedCentral, PubMed, Embase, and Cochrane Central Register of clinical trials. The following inclusion criteria were used: random allocation to treatment (“earlier” initiation of RRT versus later/standard initiation); critically ill patients. RESULTS: Ten trials randomizing 2214 patients, 1073 to earlier initiation of RRT and 1141 to later initiation were included. No difference in mortality (43.3% (465 of 1073) for those receiving early RRT and 40.8% (466 of 1141) for controls, p = 0.97) and survival without dependence on RRT (3.6% (34 of 931) for those receiving early RRT and 4.2% (40 of 939) for controls, p = 0.51) were observed in the overall population. On the contrary, early initiation of RRT was associated with a significant reduction in hospital length of stay. No differences in occurrence of adverse events were observed. CONCLUSIONS: Our study suggests that early initiation of RRT in critically ill patients with AKI does not provide a clinically relevant advantage when compared with standard/late initiation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12871-019-0733-7) contains supplementary material, which is available to authorized users. BioMed Central 2019-05-01 /pmc/articles/PMC6492439/ /pubmed/31039744 http://dx.doi.org/10.1186/s12871-019-0733-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Pasin, Laura
Boraso, Sabrina
Tiberio, Ivo
Early initiation of renal replacement therapy in critically ill patients: a meta-analysis of randomized clinical trials
title Early initiation of renal replacement therapy in critically ill patients: a meta-analysis of randomized clinical trials
title_full Early initiation of renal replacement therapy in critically ill patients: a meta-analysis of randomized clinical trials
title_fullStr Early initiation of renal replacement therapy in critically ill patients: a meta-analysis of randomized clinical trials
title_full_unstemmed Early initiation of renal replacement therapy in critically ill patients: a meta-analysis of randomized clinical trials
title_short Early initiation of renal replacement therapy in critically ill patients: a meta-analysis of randomized clinical trials
title_sort early initiation of renal replacement therapy in critically ill patients: a meta-analysis of randomized clinical trials
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492439/
https://www.ncbi.nlm.nih.gov/pubmed/31039744
http://dx.doi.org/10.1186/s12871-019-0733-7
work_keys_str_mv AT pasinlaura earlyinitiationofrenalreplacementtherapyincriticallyillpatientsametaanalysisofrandomizedclinicaltrials
AT borasosabrina earlyinitiationofrenalreplacementtherapyincriticallyillpatientsametaanalysisofrandomizedclinicaltrials
AT tiberioivo earlyinitiationofrenalreplacementtherapyincriticallyillpatientsametaanalysisofrandomizedclinicaltrials